SEARCH

SEARCH BY CITATION

References

  • 1
    Torkhovskaya T.I., Ipatova O.M., Zakhararova T.S., Kochetova M.M., Khalilov E.M. (2007) Lysophospholipid receptor in cell signaling. Biochemistry (Moscow);72:125131.
  • 2
    Meyer Zu Heringdorf D., Jakobs K.H. (2007) Lysophospholipid receptors: signaling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta;1768:923940.
  • 3
    Wymann M.P., Schneiter R. (2008) Lipid signaling in disease. Nat Rev Mol Cell Biol;9:162176.
  • 4
    Hla T. (2004) Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol;15:513520.
  • 5
    Kabarowski J.H. (2009) G2A and LPC: regulatory functions in immunity. Prostaglandins Other Lipid Mediat;89:7381.
  • 6
    Zalewski A., Macphee C.H. (2005) Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol;25:923931.
  • 7
    Muralilrishna Adibhatla R., Hatcher J.F. (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med;40:376387.
  • 8
    Kougias P., Chai H., Lin P.H., Lumsden A.B., Yao Q., Chen C. (2006) Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit;12:RA5RA16.
  • 9
    Sakai M., Miyazaki A., Hakamata H., Sasaki T., Yui S., Yamazaki M., Shichiri M., Horiuchi S. (2004) Lysophosphatidylcholine plays an essential role in the mitogenic effect of low density lipoprotein on murine macrophages. J Biol Chem;269:3143031435.
  • 10
    Nakano T., Raines E.W., Abraham J.A., Klagsbrun M., Ross R. (1994) Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA;91:10691073.
  • 11
    Huang Y.H., Schäfer-Elinder L., Wu R., Claesson H.E., Frostegård J. (1999) Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol;116:326331.
  • 12
    Kita T., Kume N., Yokode M., Ishii K., Arai H., Horiuchi H., Moriwaki H., Minami M., Kataoka H., Wakatsuki Y. (2000) Oxidized-LDL and atherosclerosis. Role of LOX-1. Ann N Y Acad Sci;902:95100.
  • 13
    Haberland M.E., Reynolds J.A. (1975) Interaction of L-α-palmitoyl lysophosphatidylcholine with the AI polypeptide of high density lipoprotein. J Biol Chem;250:66366639.
  • 14
    Hayashi H., Yamanaka T., Miyajima M., Imae T. (1994) Aggregation numbers and shapes of lysophosphatidylcholine and lysophosphatidylethanolamine micelles. Chem Lett;12:24072410.
  • 15
    Yokota K., Shimada H., Kamaguchi A., Sakaguchi O. (1977) Studies on the toxin of Aspergillus fumigatus.VII. Purification and some properties of hemolytic toxin (asp-hemolysin) from culture filtrates and mycelia. Microbiol Immunol;21:1122.
  • 16
    Ebina K., Sakagami H., Yokota K., Kondo H. (1994) Cloning and nucleotide sequence of cDNA encoding Asp-hemolysin from Aspergillus fumigatus. Biochim Biophys Acta;1219:148150.
  • 17
    Fukuchi Y., Kudo Y., Kumagai T., Ebina K., Yokota K. (1998) Oxidized low density lipoprotein inhibits the hemolytic activity of Asp-hemolysin from Aspergillus fumigatus. FEMS Microbiol Lett;167:275280.
  • 18
    Kudo Y., Kumagai T., Fukuchi Y., Ebina K., Yokota K. (1999) Binding of Asp-hemolysin from Aspergillus fumigatus to oxidized low density lipoprotein. Biol Pharm Bull;22:549550.
  • 19
    Kudo Y., Ootani T., Kumagai T., Fukuchi Y., Ebina K., Yokota K. (2002) A novel oxidized low-density lipoprotein-binding protein, Asp-hemolysin, recognizes lysophosphatidylcholine. Biol Pharm Bull;25:787790.
  • 20
    Kumagai T., Tsutsumi H., Ogawa N., Naito S., Ebina K., Yokota K., Nagata K. (2006) Oxidized low-density lipoprotein-binding specificity of the Asp-hemolysin-related synthetic peptides from Aspergillus fumigatus. Biol Pharm Bull;29:21812186.
  • 21
    Kumagai T., Ogawa N., Tsutsumi H., Ebina K., Yokota K. (2005) A synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of macrophage proliferation by oxidized low-density lipoprotein. Biol Pharm Bull;28:13811384.
  • 22
    Tsutsumi H., Kumagai T., Naitoo S., Ebina K., Yokota K. (2006) Synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of apoptosis on HUVECs by lysophosphatidylcholine. Biol Pharm Bull;29:907910.
  • 23
    Thumser A.E., Voysey J.E., Wilton D.C. (1994) The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem J;301:801806.
  • 24
    Kraft C.A., Garrido J.L., Leiva-Vega L., Romero G. (2009) Quantitative analysis of protein-lipid interactions using tryptophan fluorescence. Sci Signal;2:17.
  • 25
    Eftink M.R., Ghiron C.A. (1976) Exposure of tryptophanyl residues in proteins, quantitative determination by fluorescence quenching studies. Biochemistry;15:672680.
  • 26
    Lehrer S.S. (1971) Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry;10:32543263.
  • 27
    Hayase N., Satomi M., Hara A., Awaya T., Shimizu K., Matsubara K. (2003) Protective effects of quinaprilat and trandolaprilat, active metabolites of quinapril and trandolapril, on hemolysis induced by lysophosphatidylcholine in human erythrocytes. Biol Pharm Bull;26:712716.
  • 28
    Esposti M.D., Cristea I.M., Gaskell S.J., Nakao Y., Dive C. (2003) Proapoptopic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ;10:13001309.
  • 29
    Manara A., Lindsay J., Marchioretto M., Astegno A., Gilmore A.P., Esposti M.D., Crimi M. (2009) Bid binding to negatively charged phospholipids may not be required for its pro-apoptotic activity in vivo. Biochim Biophys Acta;1791:9971010.
  • 30
    Kovacs E., Lliom K. (2008) Sphingosylphosphorylcholine as a novel calmodulin inhibitor. Biochem J;410:427437.
  • 31
    Beechem J.M., Brand L. (1985) Time-resolved fluorescence of proteins. Annu Rev Biochem;54:4371.
  • 32
    Casals C., Miguel E., Perez-Gil J. (1993) Tryptophan fluorescence study on the interaction of pulmonary surfactant protein A with phospholipid vesicles. Biochem J;296:585593.
  • 33
    Vivian J.M., Callis P.R. (2001) Mechanisms of tryptophan fluorescence shifts in proteins. Biophys J;80:20932109.
  • 34
    Möller M., Denicola A. (2002) Protein tryptophan accessibility studied by fluorescence quenching. Biochem Mol Biol Educ;30:175178.
  • 35
    Lakowicz J.R. (1992) Topics in Fluorescence Spectroscopy – Biological Applications, Vol. 3. New York: Plenum Press.
  • 36
    Lakowicz J.R. (1983) Principles of Fluorescence Spectroscopy. New York and London: Plenum Press.
  • 37
    Stevenson S.G., Preston K.R. (1994) Intrinsic fluorescence and quenching studies of gluten proteins. Cereal Chem;71:155159.
  • 38
    Ishii I., Fukushima N., Ye X., Chun J. (2004) Lysophospholipid receptors: signaling and biology. Annu Rev Biochem;73:321354.
  • 39
    Steenbergen C., Jennings R.B. (1984) Relationship between lysophospholipid accumulation and plasma membrane injury during total in vitro ischemia in dog heart. J Mol Cell Cardiol;16:605621.
  • 40
    Ojala P.J., Hirvonen T.E., Hermansson M., Somerharju P., Parkkinen J. (2007) Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J Leukoc Biol;82:15011509.
  • 41
    Matsumoto T., Kobayashi T., Kamata K. (2007) Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem;14:32093220.
  • 42
    Jougasaki M., Kugiyama K., Saito Y., Nakao K., Imura H., Yasue H. (1992) Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low-density lipoprotein in cultured vascular endothelial cells. Circ Res;71:614619.
  • 43
    Sugiyama S., Kugiyama K., Ohgushi M., Fujimoto K., Yasue H. (1992) Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ Res;74:565575.
  • 44
    Henriksen J.R., Andresen T.L., Feldborg L.N., Duelund L., Ipsen J.H. (2010) Understanding detergent effects on lipid membranes: a model study of lysolipids. Biophys J;98:21992205.
  • 45
    Li D., Yang B., Mehta J.L. (1998) Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol;275:H568H576.
  • 46
    Matsuzaki K., Handa T., Miyajima K., Mikura Y., Shimizu H., Toguchi H. (1988) Quantitative analysis of hemolytic action of lysophosphatidylcholines in vitro: effect of acyl chain structure. Chem Pharm Bull;36:42534260.
  • 47
    Sato A., Kumagai T., Aoki J., Ebina K. (2012) Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor. Eur J Pharmacol;685:205212.